ENST00000462876.5:n.470-6552G>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000462876.5(CAV2):n.470-6552G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.327 in 151,994 control chromosomes in the GnomAD database, including 8,735 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.33 ( 8735 hom., cov: 32)
Consequence
CAV2
ENST00000462876.5 intron
ENST00000462876.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.147
Publications
6 publications found
Genes affected
CAV2 (HGNC:1528): (caveolin 2) The protein encoded by this gene is a major component of the inner surface of caveolae, small invaginations of the plasma membrane, and is involved in essential cellular functions, including signal transduction, lipid metabolism, cellular growth control and apoptosis. This protein may function as a tumor suppressor. This gene and related family member (CAV1) are located next to each other on chromosome 7, and express colocalizing proteins that form a stable hetero-oligomeric complex. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. Additional isoforms resulting from the use of alternate in-frame translation initiation codons have also been described, and shown to have preferential localization in the cell (PMID:11238462). [provided by RefSeq, May 2011]
CAV2 Gene-Disease associations (from GenCC):
- amyotrophic lateral sclerosisInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.328 AC: 49752AN: 151876Hom.: 8735 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
49752
AN:
151876
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.327 AC: 49763AN: 151994Hom.: 8735 Cov.: 32 AF XY: 0.319 AC XY: 23681AN XY: 74298 show subpopulations
GnomAD4 genome
AF:
AC:
49763
AN:
151994
Hom.:
Cov.:
32
AF XY:
AC XY:
23681
AN XY:
74298
show subpopulations
African (AFR)
AF:
AC:
17388
AN:
41424
American (AMR)
AF:
AC:
3789
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
1420
AN:
3466
East Asian (EAS)
AF:
AC:
357
AN:
5176
South Asian (SAS)
AF:
AC:
1364
AN:
4812
European-Finnish (FIN)
AF:
AC:
2413
AN:
10576
Middle Eastern (MID)
AF:
AC:
111
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21995
AN:
67954
Other (OTH)
AF:
AC:
712
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1686
3372
5058
6744
8430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
498
996
1494
1992
2490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
638
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.